SLC6A2: Sodium-dependent noradrenaline transporter
A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.
Mediates sodium- and chloride-dependent transport of norepinephrine (also known as noradrenaline), the primary signaling neurotransmitter in the autonomic sympathetic nervous system.
- Drugs that act on it: 48
- With a US drug page: 25
- Type: Protein
Drugs That Act on It
Approved and clinical-stage drugs ChEMBL records for this target; those with a US approval link to their page| Amitriptyline | Approved | Norepinephrine transporter inhibitor | Inhibitor | Boxed warning |
| Amoxapine | Approved | Norepinephrine transporter inhibitor | Inhibitor | Boxed warning |
| Atomoxetine | Approved | Norepinephrine transporter inhibitor | Inhibitor | Boxed warning |
| Benzphetamine | Approved | Norepinephrine transporter releasing agent | Releasing agent | — |
| Bethanidine | Approved | Norepinephrine transporter substrate | Substrate | — |
| Bretylium | Approved | Norepinephrine transporter substrate | Substrate | — |
| Desipramine | Approved | Norepinephrine transporter inhibitor | Inhibitor | Boxed warning |
| Dexmethylphenidate | Approved | Norepinephrine transporter inhibitor | Inhibitor | Boxed warning |
| Diethylpropion | Approved | Norepinephrine transporter inhibitor | Inhibitor | Withdrawn |
| Doxepin | Approved | Norepinephrine transporter inhibitor | Inhibitor | Boxed warning |
| Duloxetine | Approved | Norepinephrine transporter inhibitor | Inhibitor | Boxed warning |
| Guanadrel | Approved | Norepinephrine transporter substrate | Substrate | — |
| Imipramine | Approved | Norepinephrine transporter inhibitor | Inhibitor | Boxed warning |
| Levomilnacipran | Approved | Norepinephrine transporter inhibitor | Inhibitor | Boxed warning |
| Maprotiline | Approved | Norepinephrine transporter inhibitor | Inhibitor | Boxed warning |
| Milnacipran | Approved | Norepinephrine transporter inhibitor | Inhibitor | Boxed warning |
| Nefazodone | Approved | Norepinephrine transporter inhibitor | Inhibitor | WithdrawnBoxed warning |
| Nortriptyline | Approved | Norepinephrine transporter inhibitor | Inhibitor | Boxed warning |
| Phendimetrazine | Approved | Norepinephrine transporter inhibitor | Inhibitor | Withdrawn |
| Phenmetrazine | Approved | Norepinephrine transporter inhibitor | Inhibitor | — |
| Phentermine | Approved | Norepinephrine transporter releasing agent | Releasing agent | Withdrawn |
| Protriptyline | Approved | Norepinephrine transporter inhibitor | Inhibitor | Boxed warning |
| Tapentadol | Approved | Norepinephrine transporter inhibitor | Inhibitor | Boxed warning |
| Trimipramine | Approved | Norepinephrine transporter inhibitor | Inhibitor | Boxed warning |
| Viloxazine | Approved | Norepinephrine transporter inhibitor | Inhibitor | — |
| Amphetamine | — | Norepinephrine transporter releasing agent | Releasing agent | Boxed warning |
| Ampreloxetine | — | Norepinephrine transporter inhibitor | Inhibitor | — |
| Bupropion | — | Norepinephrine transporter inhibitor | Inhibitor | Boxed warning |
| Debrisoquin | — | Norepinephrine transporter inhibitor | Inhibitor | — |
| Desvenlafaxine | — | Norepinephrine transporter inhibitor | Inhibitor | Boxed warning |
| Dextroamphetamine | — | Norepinephrine transporter releasing agent | Releasing agent | Boxed warning |
| Dibenzepin | — | Norepinephrine transporter inhibitor | Inhibitor | Withdrawn |
| Dothiepin | — | Norepinephrine transporter inhibitor | Inhibitor | — |
| Edivoxetine | — | Norepinephrine transporter inhibitor | Inhibitor | — |
| Esreboxetine | — | Norepinephrine transporter inhibitor | Inhibitor | — |
| Faxeladol | — | Norepinephrine transporter inhibitor | Inhibitor | — |
| Guanethidine | — | Norepinephrine transporter substrate | Substrate | — |
| Iobenguane | — | Norepinephrine transporter substrate | Substrate | — |
| Lisdexamfetamine | — | Norepinephrine transporter releasing agent | Releasing agent | Boxed warning |
| Methylphenidate | — | Norepinephrine transporter inhibitor | Inhibitor | Boxed warning |
| Midomafetamine | — | Sodium-dependent noradrenaline transporter releasing agent | Releasing agent | — |
| Orphenadrine | — | Norepinephrine transporter inhibitor | Inhibitor | — |
| Phenylpropanolamine | — | Norepinephrine transporter releasing agent | Releasing agent | Withdrawn |
| Pseudoephedrine | — | Norepinephrine transporter releasing agent | Releasing agent | — |
| Reboxetine | — | Norepinephrine transporter inhibitor | Inhibitor | — |
| Serdexmethylphenidate | — | Norepinephrine transporter inhibitor | Inhibitor | — |
| Tedatioxetine | — | Norepinephrine transporter inhibitor | Inhibitor | — |
| Venlafaxine | — | Norepinephrine transporter inhibitor | Inhibitor | Boxed warning |
Diseases Most Associated With It
Open Targets association score, 0 to 1; all associations- Obesity disorder
- 0.60
- Fibromyalgia
- 0.60
- Nasal congestion
- 0.60
- Common cold
- 0.60
- Pain
- 0.60
- Neuropathic pain
- 0.58
- Cough
- 0.58
- Anxiety disorder
- 0.58
Genes and Related Targets
Complexes and families that share a gene with this target- Genes
- SLC6A2
Drugs and mechanisms are from ChEMBL CHEMBL222 (CC BY-SA 3.0). Gene name, function (UniProt P23975, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets